Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

First AI-enabled POCUS app for detecting pleural effusion and atelectasis earns FDA clearance
The apps are embedded into the Exo Iris transducer, which can be plugged directly into a smartphone, utilized anywhere and without the internet.
Symptom-detected breast cancers more likely to require mastectomy, chemotherapy
New research adds to the “strong evidence” supporting screening guidelines and highlights the importance of women adhering to clinical recommendations.
Shoulder ultrasound effectively detects insulin resistance, even before abnormal labs
POCUS could represent a quick, easy and affordable way to detect signs of insulin resistance before it progresses into diabetes, researchers suggest.
Contrast-enhanced mammography significantly improves early cancer detection
New trial results suggest CEM could enhance breast cancer detection beyond DBT exams when patients are faced with barriers to obtaining an MRI.
Bayer seeks FDA approval for gadoquatrane, its latest low-dose GBCA
The investigational agent uses 60% less gadolinium without sacrificing image quality, according to recent clinical trial findings.

Helga and Zohar, the phantom passengers, on the flight deck of the Orion spacecraft. NASA/LM/DLR photo

NASA's Artemis 1 moon mission using phantom technology familiar to imaging specialists

Ehsan Samei, PhD, president-elect of the American Association of Physicists in Medicine, helped NASA build medical phantoms that are literally out of this world. Samei detailed the project at RSNA 2022 in Chicago.

Follow-up recommendations after abnormal mammograms often ignored due to high deductibles

Although the Affordable Care Act eliminated OOP costs for screening mammograms under most insurance plans, that coverage does not carry over to the additional exams that are needed when abnormal findings are uncovered.

Deductibles may prevent women from seeking follow-up breast cancer screenings

A patient survey revealed that more than one in five women would likely skip indicated follow-up screenings if they had to pay a deductible, even if an initial mammogram revealed abnormalities.

Opto-acoustic Imaging: A new modality changing the future of breast imaging

Sponsored by Seno Medical

When it comes to breast imaging, a few new technologies have improved the visualization of lesions and diagnostic procedures. But a new modality could change the game completely.

Canon to open new subsidiary, Canon Healthcare USA, in Cleveland

“The U.S. market is more and more important for our business,” the company's president and CEO said during a press conference at RSNA 2022.

Many providers remain underinformed about increased cancer risks associated with breast density

JoAnn Pushkin, breast cancer survivor and executive director of DenseBreast-info.org, sounded the alarm on the lack of awareness surrounding breast density and its associated cancer risks during a presentation at this year’s annual RSNA meeting.

New AI model calculates risk of heart attack or stroke using a single X-ray

“This type of screening could be used to identify individuals who would benefit from statin medication but are currently untreated," one specialist said. The full analysis will be presented at RSNA 2022 in Chicago.

Imaging research links obesity to poor brain health in children

The team will share its findings, based on imaging data from more than 5,000 pediatric patients, at RSNA 2022 in Chicago.

Medical Imaging

First AI-enabled POCUS app for detecting pleural effusion and atelectasis earns FDA clearance

Symptom-detected breast cancers more likely to require mastectomy, chemotherapy

Shoulder ultrasound effectively detects insulin resistance, even before abnormal labs

Contrast-enhanced mammography significantly improves early cancer detection

Bayer seeks FDA approval for gadoquatrane, its latest low-dose GBCA